Skip to main content
SpringerLink
Log in

Clinical Features of Myositis: Arthritis, Raynaud Phenomenon, Constitutional

  • Chapter
  • First Online:
Managing Myositis

  • 905 Accesses

Abstract

The extramuscular features of the idiopathic inflammatory myopathies (IIM) include arthritis, Raynaud’s phenomenon and constitutional symptoms such as fatigue, fever and weight loss. These features may predate the onset of myositis symptoms. Arthritis most commonly manifests in patients with anti-Jo-1 autoantibodies and the anti-synthetase syndrome, as does Raynaud’s phenomenon. The arthritis seen in this subgroup of patients is typically non-erosive, but can be deforming. Constitutional symptoms are a common early symptom but also reoccur with disease flares.

In this chapter, we aim to present the extramuscular features of myositis patients and find in which subgroups they frequently occur.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.

    Article  CAS  Google Scholar 

  2. Hervier B, Devilliers H, Stanciu R, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev. 2012;12:210–7.

    Article  CAS  Google Scholar 

  3. Meyer A, Lefevre G, Bierry G, et al. In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis. Medicine (Baltimore). 2015;94:e523.

    Article  CAS  Google Scholar 

  4. Labrador-Horrillo M, Martinez MA, Selva-O’Callaghan A, Delgado JF, Martinez-Gomez X, Trallero-Araguas E, Rodriguez-Sanchez JL, Vilardell-Tarres M. Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy. Rheumatology. 2009;48:676–9.

    Article  CAS  Google Scholar 

  5. Meyer O, Charlanne H, Cherin P, Allanore Y, Coquerelle P, Grardel B, Chamot A-M, Hachulla E, Inflammation CRE. Subluxing arthropathy: an unusual manifestation of the antisynthetase syndrome. Ann Rheum Dis. 2009;68:152–3.

    Article  CAS  Google Scholar 

  6. Cavagna L, Nuño L, Scirè CA, et al. Serum Jo-1 autoantibody and isolated arthritis in the antisynthetase syndrome: review of the literature and report of the experience of AENEAS Collaborative Group. Clin Rev Allergy Immunol. 2017;52:71–80.

    Article  CAS  Google Scholar 

  7. Cavagna L, Nuño L, Scirè CA, et al. Clinical spectrum time course in Anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study. Medicine (Baltimore). 2015;94:e1144.

    Article  CAS  Google Scholar 

  8. Oddis CV, Medsger TA, Cooperstein LA. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Arthritis Rheum. 1990;33:1640–5.

    Article  CAS  Google Scholar 

  9. Kaneko Y, Hanaoka H, Hirakata M, Takeuchi T, Kuwana M. Distinct arthropathies of the hands in patients with anti-aminoacyl tRNA synthetase antibodies: usefulness of autoantibody profiles in classifying patients. Rheumatology (Oxford). 2014;53:1120–4.

    Article  CAS  Google Scholar 

  10. Oztürk MA, Unverdi S, Goker B, Haznedaroglu S, Tunç L. A patient with antisynthetase syndrome associated with deforming arthritis and periarticular calcinosis sine myositis. Scand J Rheumatol. 2007;36:239–41.

    Article  Google Scholar 

  11. Labirua-Iturburu A, Selva-O’Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, Charles P, Dastmalchi M, Lundberg IE. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome. Medicine (Baltimore). 2012;91:206–11.

    Article  CAS  Google Scholar 

  12. Dobloug C, Garen T, Bitter H, Stjärne J, Stenseth G, Grøvle L, Sem M, Gran JT, Molberg Ø. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis. 2015;74:1551–6.

    Article  Google Scholar 

  13. Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, Oddis CV. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis. 2014;73:227–32.

    Article  Google Scholar 

  14. Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J. 2011;41:674–9.

    Article  CAS  Google Scholar 

  15. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One. 2013;8:e60442.

    Article  CAS  Google Scholar 

  16. Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L. Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis. J Am Acad Dermatol. 2015;72:449–55.

    Article  Google Scholar 

  17. Manfredi A, Sebastiani M, Cassone G, Pipitone N, Giuggioli D, Colaci M, Salvarani C, Ferri C. Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol. 2015;34:279–84.

    Article  CAS  Google Scholar 

  18. Selva-O’Callaghan A, Fonollosa-Pla V, Trallero-Araguás E, Martínez-Gómez X, Simeon-Aznar CP, Labrador-Horrillo M, Vilardell-Tarrés M. Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum. 2010;39:398–404.

    Article  Google Scholar 

  19. Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Horie S, Yahata T, Inoue K, Someya F, Fujimoto M, Takehara K. Association between nail-fold capillary findings and disease activity in dermatomyositis. Rheumatology (Oxford). 2011;50:1091–8.

    Article  Google Scholar 

  20. Pinal-Fernandez I, Fonollosa-Pla V, Selva-O’Callaghan A. Improvement of the nailfold capillaroscopy after immunosuppressive treatment in polymyositis. QJM. 2016;109:205–6.

    Article  CAS  Google Scholar 

  21. de SFHC, Barros TBM, Levy-Neto M, Shinjo SK. Adult dermatomyositis: experience of a Brazilian tertiary care center. Rev Bras Reumatol. 2012;52:897–902.

    Article  Google Scholar 

  22. De Souza FHC, Miossi R, Shinjo SK. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody. Clin Exp Rheumatol. 2017;35:766.

    PubMed  Google Scholar 

  23. Lorenzoni PJ, Scola RH, Kay CSK, Prevedello PG, Espíndola G, Werneck LC. Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases. Pediatr Neurol. 2011;45:17–22.

    Article  Google Scholar 

  24. Shinjo SK, Levy-Neto M. Anti-Jo-1 antisynthetase syndrome. Rev Bras Reumatol. 50:492–500.

    Google Scholar 

  25. Park JK, Mecoli CA, Alexanderson H, et al. Advancing the development of patient-reported outcomes for adult myositis at OMERACT 2016: An International Delphi Study. J Rheumatol. 2017:jrheum.161252.

    Google Scholar 

  26. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford). 2002;41:22–6.

    Article  CAS  Google Scholar 

  27. Weinstein AA, Drinkard BM, Diao G, Furst G, Dale JK, Straus SE, Gerber LH. Exploratory analysis of the relationships between aerobic capacity and self-reported fatigue in patients with rheumatoid arthritis, polymyositis, and chronic fatigue syndrome. PM R. 2009;1:620–8.

    Article  Google Scholar 

  28. Campbell R, Gordon P, Ward K, Reilly C, Scott DL, Rafferty GF. Nonvolitional assessment of muscle endurance in idiopathic inflammatory myopathies: there is no relationship between patient-reported fatigue and muscle fatigability. Muscle Nerve. 2014;50:401–6.

    Article  Google Scholar 

  29. Butbul Aviel Y, Stremler R, Benseler SM, et al. Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Rheumatology (Oxford). 2011;50:2051–60.

    Article  Google Scholar 

  30. Ramkumar S, Raghunath A, Raghunath S. Statin therapy: review of safety and potential side effects. Acta Cardiol Sin. 2016;32:631–9.

    PubMed  PubMed Central  Google Scholar 

  31. Zhan Q, Wang G, Liu X, et al. A multi-center retrospective study of organ involvement in adult patients with polymyositis or dermatomyositis. Zhonghua Yi Xue Za Zhi. 2014;94:43–6.

    PubMed  Google Scholar 

  32. Elam MB, Majumdar G, Mozhui K, Gerling IC, Vera SR, Fish-Trotter H, Williams RW, Childress RD, Raghow R. Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge. PLoS One. 2017;12:e0181308.

    Article  Google Scholar 

  33. Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, et al. Analysis of vitamin D levels in patients with and without statin-associated myalgia — a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol. 2015;178:111–6.

    Article  Google Scholar 

  34. Taylor BA, Lorson L, White CM, Thompson PD. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain. Atherosclerosis. 2017;256:100–4.

    Article  CAS  Google Scholar 

Download references

Conflicts of Interest

There are no conflicts of interest to be declared.

Author information

Authors and Affiliations

  1. Centre for Rheumatology, Division of Medicine, University College London, London, UK

    Kristina E. N. Clark & David A. Isenberg

Authors
  1. Kristina E. N. Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David A. Isenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A. Isenberg .

Editor information

Editors and Affiliations

  1. Division of Rheumatology and Clinical Immunology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA

    Rohit Aggarwal

  2. Division of Rheumatology and Clinical Immunology, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA

    Chester V. Oddis

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Clark, K.E.N., Isenberg, D.A. (2020). Clinical Features of Myositis: Arthritis, Raynaud Phenomenon, Constitutional. In: Aggarwal, R., Oddis, C. (eds) Managing Myositis. Springer, Cham. https://doi.org/10.1007/978-3-030-15820-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-15820-0_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-15819-4

  • Online ISBN: 978-3-030-15820-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation